17.11.2026 04:13
Europe Approves First RAS-Targeted Drug For Metastatic Pancreatic Cancer — Daraxonrasib
Daraxonrasib: Europe Approves First RAS-Targeted Drug For Metastatic Pancreatic Cancer Health and Me
Original report →Health and Me is a news source represented in the EUROSMI news feed. This page collects recent reports, links to original publications and background information. Editorial details about the source are expanded after verification against official information.
Daraxonrasib: Europe Approves First RAS-Targeted Drug For Metastatic Pancreatic Cancer Health and Me
Original report →EUROSMI does not own this publication. Names and trademarks belong to their respective rights holders.